Abstract
Providencia stuartii strains in the context of persistent bacteriuria in patients catheterized over four 106 or more weeks (24). In a study examining 4,500 urine samples from repeatedly catheterized spinal 107 cord-injured patients, the incidences of UTI with one and two or more identified bacterial species 108 were 45% and 15%, respectively (25). A third study revealed polymicrobial colonization by two to 109 four common uropathogens in 20 patients (26). Notably, antibiotic treatments altered the 110 composition of CBs and failed to clear pathogens from the patients' urinary tracts (26).
111
Bladder catheterization itself was reported to cause sterile inflammation in a murine model, 112 with CD 45+ neutrophils as the main infiltrating immune cells. Using this model, E. coli and E.
113
faecalis infections were shown to cause urothelial barrier disruption and further immune cell 114 infiltration (27). Pyuria is known to occur in patients with indwelling catheters independent of the 115 symptomology (7). Our recent work revealed neutrophil and complement system activation at 116 similar levels in patients diagnosed with CAASB and CAUTI after catheterization at a single 117 timepoint (28). Here, we publish the first comprehensive analyses of catheter biofilms associated 118 with recurrent catheterization of patients. We used 16S rRNA taxonomic and proteomic analyses, 119 and further validated results of the host-microbial crosstalk with biochemical and microbial culture 120 methods.
121

Results
123
Patient cohort, antibiotic treatments and phenotypic observations. 124 We enrolled two female and seven male human subjects of either hispanic or caucasian 125 ethnicities. All of them had spinal cord injuries and suffered from neurogenic bladder syndrome.
126
Comorbidities were chronically infected wounds. During the patient visits for wound treatment, 127 indwelling bladder catheters were usually replaced. All patients received topical wound treatments 128 with antibiotic drugs. Systemic antibiotic treatments over a limited time pertained to three patients 129 while this study was conducted. The drug treatment regimens and other medical data are provided 130 in Table S1 (Suppl. Data). Patient P6 was diagnosed with a renal infection a month after specimen 131 collections ended, probably via ascension of catheter-associated pathogens to the kidneys. UTI 132 symptoms were not reported by patients while the study was performed, which is consistent with 133 diagnoses of CAASB. Catheters were replaced in 1-to 3-week intervals to reduce risk of CAUTI 134 and renal complications. We analyzed urine sediments collected as centrifugal pellets from 135 catheter collection bags and biofilms extracted from external and internal catheter surfaces. The 136 terms used for these specimens are UP and CB, respectively, and are from here on. They were 137 collected longitudinally from patients over 2 to 6 months, ranging from 4 to 15 timepoints. Some 138 timepoints were represented by only a CB, a UP or both types of samples. Catheter encrustation 139 was observed for several samples from P4, P5, P6, and P7 (Table S1 , Suppl. Data). The variation 140 in CB biomasses among the patients is displayed in Fig. 1 and P7 samples (Fig. 4) and most abundant in P1 and P2 datasets (Fig. 4) . Some E. coli strains produce another 246 siderophore, aerobactin, via the system IucA-D. Its receptor IutA (Fig. 4) phosphate salts and are used by the bacteria to establish co-aggregates with salts (3, 11, 12, 26).
437
Our UP and CB proteome data strongly support the notion that distinct strains of a given 438 microbe dominate the CB community of a given patient, as compared to a mixture of strains.
439
While absolute evidence to back up this claim requires analysis of the strains' genomes in a series 440 of CBs, which we plan to do in future work, identification of genes not part of a species' core genome in some but not other patients allow this conclusion. were recovered that we termed CB-1 (Na-acetate buffer) and CB-2 (SED solution). The extraction 590 of UP samples was limited to solubilization in SED solution. Experimental details were described 591 previously (28, 31). All centrifugal centrifugation steps were performed using Ultrafree-4 filter units Computational proteomic data analyses and proteome quantifications.
630
The raw MS files were combined for database searches as follows: (1) all technical replicates for a 631 given UP sample; (2) all replicates from both CB-1 and CB-2 fractions for a given CB sample. The The 'protein grouping' function was enabled to ensure that only one protein was reported when MiSeq sequencer from Illumina Inc. were described previously (72). The UPARSE pipeline for the 662 phylogenetic analysis was used (73). OTUs were generated de novo from raw sequence reads 663 using default parameters in UPARSE, the Wang classifier and bootstrapping using 100 iterations.
664
The taxonomies were assigned to the OTUs using Thermal shift assay.
702
Interaction of proteins with a small molecule can increase its stability and the melting temperature Disk diffusion antibiotic drug susceptibility tests.
714
We followed guidelines from a Manual of Antimicrobial Susceptibility Testing (79) to perform drug 715 susceptibility tests via disk diffusion. All antibiotics were dissolved as specified by the Korean society of laboratory medicine manual and placed on 0.6 mm disks in concentrations as follows: to wet pellet weights in g x 10 -2 for ~ 1.5-inch catheter pieces. The CB extracts were washed in PBS, thus 948 dissolving salt crystals that did not contribute to pellet weights. The horizontal bars depict statistically 949 significant weight differences comparing datasets from individual patients. Significance levels are coded 950 ***=0.001, **=0.01, and *=0.05, using the Wilcoxon rank sum test. 951 respectively. 16S rDNA data for UP and CB samples derived from the same timepoint were separate 954 entries. NE and SE diversities were statistically different based on a Wilcoxon rank sum test (P-value < 955 0.05). 956 plot. The significance levels are coded as ***=0.001, **=0.01, and *=0.05. The Wilcoxon rank sum test was 969 used to determine statistically significant differences in patient-to-patient comparisons (p-value < 0.05). 970 
